Medicare Cancer Drug Administration Code Changes Follow AMA Proposal
Executive Summary
The Centers for Medicare & Medicaid Services will implement new codes for oncology care based on American Medical Association recommendations
You may also be interested in...
Medicare Part B Demo, Coding Changes Will Stabilize Oncology Rx Market
The Centers for Medicare & Medicaid Services expects the combination of a new oncology "quality of care" demonstration project and the adoption of new billing codes to help smooth the transition to ASP-based reimbursement in 2005
Medicare Part B Demo, Coding Changes Will Stabilize Oncology Rx Market
The Centers for Medicare & Medicaid Services expects the combination of a new oncology "quality of care" demonstration project and the adoption of new billing codes to help smooth the transition to ASP-based reimbursement in 2005
Procrit, Camptosar At Risk Under 2005 Medicare Payment Rates, ASCO Says
Medicare reimbursement rates for 2005 will not cover costs of Johnson & Johnson's Procrit (epoetin) for the majority of oncology practices, according to the American Society of Clinical Oncology